Symbol="CCCC"
AssetType="Common Stock"
Name="C4 TherapeuticsÂ Inc"
Description="C4 Therapeutics, Inc., a biopharmaceutical company, develops new therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. The company is headquartered in Watertown, Massachusetts."
CIK="1662579"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="490 ARSENAL WAY, SUITE 200, WATERTOWN, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="162892000"
EBITDA="-132477000"
PERatio="None"
PEGRatio="None"
BookValue="5.35"
DividendPerShare="0"
DividendYield="0"
EPS="-2.67"
RevenuePerShareTTM="0.556"
ProfitMargin="0"
OperatingMarginTTM="-4.941"
ReturnOnAssetsTTM="-0.184"
ReturnOnEquityTTM="-0.419"
RevenueTTM="27201000"
GrossProfitTTM="-86745000"
DilutedEPSTTM="-2.67"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.509"
AnalystTargetPrice="20"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="8.15"
PriceToBookRatio="1.208"
EVToRevenue="3.285"
EVToEBITDA="-1.541"
Beta="2.098"
num_52WeekHigh="13.23"
num_52WeekLow="2.6"
num_50DayMovingAverage="3.203"
num_200DayMovingAverage="5.95"
SharesOutstanding="49063800"
DividendDate="None"
ExDividendDate="None"
symbol="CCCC"
open="3.16"
high="3.91"
low="3.13"
price="3.71"
volume="6298396.00"
latest_trading_day="2023-07-06"
previous_close="3.32"
change="0.39"
change_percent="11.7470%"
aroon_positive_momentum_days="4"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="TRUE"
Aroon_momentum="4"
Volume_recent_avg="972515"
Change_recent_avg="-0.02"
Delta_recent_avg="0.27"
Variance_recent_avg="0.14"
Change_ratio_recent_avg="-0.72"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="positive"
Aroon_change="TRUE"
Aroon_momentum_positive="4"
Aroon_momentum_negative="96"
image_negative_thumbnail_id_1="1122"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0155.jpeg"
image_negative_thumbnail_id_2="120"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0056.jpeg"
image_neutral_thumbnail_id_1="569"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0030.jpeg"
image_neutral_thumbnail_id_2="558"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0041.jpeg"
image_positive_thumbnail_id_1="638"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0070.jpeg"
image_positive_thumbnail_id_2="987"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0149.jpeg"
image_professor_thumbnail_id_1="1169"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
image_professor_thumbnail_id_2="1198"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0032.jpeg"
